Baseline C-reactive protein predicts efcacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: A retrospective, multicenter study

To investigate the predictive value of baseline C-reactive protein (CRP) levels on the efcacy of chemotherapy plus immune checkpoint inhibitors (ICI) in patients with advanced lung squamous cell carcinoma (LSCC).